Agilent Technologies A
$170.38 −$4.96 (-2.83%)
Market closed · Nov 20, 9:50 pm ET · Last extended-hours $170.00 -0.22%
Open$175.10
Prev close$175.34
Day range$169.40 – $175.13
Volume1.88M
Market cap$48.04B
P/E (TTM)33.6
Dividend yield0.59%
Fundamentals
Latest reported quarter: Q3, ended Jul 2026
Revenue$1.88B+8.1% YoY
Operating profit$444.00M+23.3% YoY
Net profit$362.00M+7.7% YoY
Diluted EPS$1.28+8.5% YoY
Free cash flow$439.00M+69.5% YoY
Operating cash flow$519.00M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin53.8%
Operating margin22.2%
Net margin19.5%
Return on equity21.0%
Return on assets11.0%
Return on invested capital14.0%
Current ratio2.05
Liabilities / assets47.3%
Cash & investments$1.76B
Total debt$3.95B
Net cash (debt)-$2.19B
Free cash flow / sales17.2%
Where the revenue comes from
Quarter 2026/Q3
By business line
SEC annual financial snapshot
Standard US-GAAP figures from 10-K filings in USD. Figures may reflect restatements. Checked 2026-11-21 16:51 UTC.
| Metric | USD | Basis | Period end | Filed / SEC source |
|---|---|---|---|---|
| Revenue | $6.95B | Annual | 2025-10-31 | 2025-12-22 |
| Net income | $1.30B | Annual | 2025-10-31 | 2025-12-22 |
| Operating cash flow | $1.56B | Annual | 2025-10-31 | 2025-12-22 |
| Total assets | $12.73B | Period end | 2025-10-31 | 2025-12-22 |
| Total liabilities | $5.99B | Period end | 2025-10-31 | 2025-12-22 |
| Stockholders’ equity | $6.74B | Period end | 2025-10-31 | 2025-12-22 |
| Cash and cash equivalents | $1.79B | Period end | 2025-10-31 | 2025-12-22 |
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $1.88B | $1.84B | $1.80B | $6.95B | $1.86B |
| Total Operating Revenue | $1.88B | $1.84B | $1.80B | $6.95B | $1.86B |
| Cost of Revenue | $836.00M | $845.00M | $852.00M | $3.31B | $871.00M |
| Gross Profit | $1.04B | $990.00M | $946.00M | $3.64B | $990.00M |
| Operating Expense | $598.00M | $591.00M | $593.00M | $2.16B | $547.00M |
| Selling and Admin Expenses | $475.00M | $465.00M | $476.00M | $1.71B | $428.00M |
| Research & Development | $123.00M | $126.00M | $117.00M | $455.00M | $119.00M |
| Operating Profit | $444.00M | $399.00M | $353.00M | $1.48B | $443.00M |
| Net Non-Operating Interest Income (Expense) | -$14.00M | -$12.00M | -$10.00M | -$50.00M | -$10.00M |
| Non-Operating Interest Income | $15.00M | $13.00M | $15.00M | $62.00M | $17.00M |
| Non-Operating Interest Expense | $29.00M | $25.00M | $25.00M | $112.00M | $27.00M |
| Other Income (Expense) | $14.00M | $21.00M | $21.00M | $6.00M | $9.00M |
| Other Non-Operating Income (Expenses) | $14.00M | $21.00M | $21.00M | $6.00M | $9.00M |
| Pretax Profit | $444.00M | $408.00M | $364.00M | $1.44B | $442.00M |
| Tax | $82.00M | $69.00M | $59.00M | $132.00M | $8.00M |
| Net Profit | $362.00M | $339.00M | $305.00M | $1.30B | $434.00M |
| Profit from Continuing Operations | $362.00M | $339.00M | $305.00M | $1.30B | $434.00M |
| Net Income to Parent Company | $362.00M | $339.00M | $305.00M | $1.30B | $434.00M |
| Net Income to Common Stockholders | $362.00M | $339.00M | $305.00M | $1.30B | $434.00M |
| Basic EPS | $1.28 | $1.20 | $1.08 | $4.59 | $1.53 |
| Diluted EPS | $1.28 | $1.20 | $1.07 | $4.57 | $1.53 |
| Dividend Per Share | $0.26 | $0.26 | $0.26 | $0.99 | $0.25 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $13.97B | $13.07B | $12.81B | $12.73B | $12.73B |
| Total Current Assets | $4.69B | $4.76B | $4.62B | $4.59B | $4.59B |
| Cash and Cash Equivalents & Short-Term Investments | $1.76B | $1.81B | $1.76B | $1.79B | $1.79B |
| -Cash and Cash Equivalents | $1.76B | $1.81B | $1.76B | $1.79B | $1.79B |
| Receivables | $1.48B | $1.50B | $1.52B | $1.49B | $1.49B |
| -Accounts Receivable | $1.48B | $1.50B | $1.52B | $1.49B | $1.49B |
| Inventory | $1.12B | $1.09B | $1.06B | $1.03B | $1.03B |
| Other Current Assets | $340.00M | $369.00M | $277.00M | $293.00M | $293.00M |
| Total Non-Current Assets | $9.27B | $8.30B | $8.20B | $8.13B | $8.13B |
| Net PPE | $2.13B | $2.10B | $2.08B | $2.02B | $2.02B |
| Investments and Advances | $130.00M | $136.00M | $135.00M | $133.00M | $133.00M |
| Goodwill and Other Intangible Assets | $5.94B | $4.89B | $4.91B | $4.92B | $4.92B |
| -Goodwill | $5.03B | $4.48B | $4.48B | $4.47B | $4.47B |
| -Other Intangible Assets | $906.00M | $407.00M | $426.00M | $445.00M | $445.00M |
| Other Non-Current Assets | $1.07B | $1.18B | $1.08B | $1.06B | $1.06B |
| Total Liabilities | $6.60B | $5.94B | $5.91B | $5.99B | $5.99B |
| Total Current Liabilities | $2.29B | $2.27B | $2.23B | $2.35B | $2.35B |
| Payables | $608.00M | $615.00M | $602.00M | $570.00M | $570.00M |
| -Accounts Payable | $608.00M | $615.00M | $602.00M | $570.00M | $570.00M |
| Current Accrued Expenses | $314.00M | $298.00M | $349.00M | $406.00M | $406.00M |
| Short-Term Debt and Capital Lease Obligation | $304.00M | $304.00M | $304.00M | $304.00M | $304.00M |
| -Current Debt | $304.00M | $304.00M | $304.00M | $304.00M | $304.00M |
| Current Deferred Liabilities | $640.00M | $665.00M | $682.00M | $624.00M | $624.00M |
| Total Non-Current Liabilities | $4.32B | $3.67B | $3.67B | $3.64B | $3.64B |
| Long Term Debt and Capital Lease Obligation | $3.65B | $3.05B | $3.05B | $3.05B | $3.05B |
| -Long Term Debt | $3.65B | $3.05B | $3.05B | $3.05B | $3.05B |
| Employee Benefits | $128.00M | $127.00M | $130.00M | $126.00M | $126.00M |
| Other Non-Current Liabilities | $542.00M | $496.00M | $491.00M | $463.00M | $463.00M |
| Total Equity | $7.36B | $7.12B | $6.91B | $6.74B | $6.74B |
| Stockholders' Equity | $7.36B | $7.12B | $6.91B | $6.74B | $6.74B |
| Capital Stock | $3.00M | $3.00M | $3.00M | $3.00M | $3.00M |
| -Common Stock | $3.00M | $3.00M | $3.00M | $3.00M | $3.00M |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $5.68B | $5.63B | $5.61B | $5.58B | $5.58B |
| Retained Earnings | $1.91B | $1.69B | $1.48B | $1.39B | $1.39B |
| Gains/Losses Not Affecting Retained Earnings | -$233.00M | -$202.00M | -$184.00M | -$226.00M | -$226.00M |
| -Gross PPE | – | – | – | $3.45B | $3.45B |
| -Accumulated Depreciation | – | – | – | -$1.42B | -$1.42B |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $519.00M | $277.00M | $268.00M | $1.56B | $545.00M |
| Net cash flow from continuing operations | $519.00M | $277.00M | $268.00M | $1.56B | $545.00M |
| Net Income from Continuing Operations | $362.00M | $339.00M | $305.00M | $1.30B | $434.00M |
| Gain/Loss from Continuing Operations | $3.00M | $1.00M | -$2.00M | $36.00M | $8.00M |
| Depreciation & Depletion & Amortization | $66.00M | $67.00M | $67.00M | $288.00M | $71.00M |
| Deferred Tax | $20.00M | $32.00M | $25.00M | -$130.00M | -$95.00M |
| Other Non-Cash Items | $18.00M | $17.00M | $12.00M | $50.00M | $16.00M |
| Change in Working Capital | $18.00M | -$211.00M | -$180.00M | -$131.00M | $85.00M |
| -Change in Receivables | $22.00M | $12.00M | -$18.00M | -$149.00M | -$105.00M |
| -Change in Inventory | -$25.00M | -$46.00M | -$39.00M | -$97.00M | -$25.00M |
| -Change in Payables and Accrued Expense | -$13.00M | $15.00M | $39.00M | $16.00M | $29.00M |
| -Change In Other Working Capital | $34.00M | -$192.00M | -$162.00M | $99.00M | $186.00M |
| Net cash flow from investing | -$1.03B | -$77.00M | -$93.00M | -$394.00M | -$90.00M |
| Net Cash Flow from Continuing Investing Activities | -$1.03B | -$77.00M | -$93.00M | -$394.00M | -$90.00M |
| Net PPE Purchase and Sale | -$80.00M | -$76.00M | -$93.00M | -$407.00M | -$93.00M |
| Net Business Purchase and Sale | -$950.00M | $0.00 | $0.00 | $4.00M | $0.00 |
| Net Other Investing Changes | -$2.00M | – | – | $1.00M | $0.00 |
| Financing Cash Flow | $471.00M | -$144.00M | -$222.00M | -$715.00M | -$200.00M |
| Net Cash Flow from Continuing Financing Activities | $471.00M | -$144.00M | -$222.00M | -$715.00M | -$200.00M |
| Net Issuance Payments Of Debt | $597.00M | -$3.00M | -$2.00M | -$41.00M | -$56.00M |
| Net Common Stock Issuance | -$78.00M | -$65.00M | -$152.00M | -$425.00M | -$85.00M |
| Cash Dividends Paid | -$72.00M | -$72.00M | -$72.00M | -$282.00M | -$70.00M |
| Proceeds from Stock Option Exercised | $31.00M | $1.00M | $31.00M | $72.00M | $12.00M |
| Net Other Financing Charges | -$7.00M | -$5.00M | -$27.00M | -$39.00M | -$1.00M |
| Ending Cash Balance | $1.76B | $1.81B | $1.76B | $1.79B | $1.79B |
| Net Change in Cash | -$42.00M | $56.00M | -$47.00M | $450.00M | $255.00M |
| Beginning Cash Balance | $1.81B | $1.76B | $1.79B | $1.33B | $1.54B |
| Effect of Exchange Rate Changes | -$7.00M | -$7.00M | $16.00M | $9.00M | -$1.00M |
| Free Cash Flow | $439.00M | $201.00M | $175.00M | $1.15B | $452.00M |
| Net Investment Purchase and Sale | – | – | – | $8.00M | $3.00M |
No comments yet — be the first to weigh in on A.
Sign in to join the discussion.